Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV

被引：122

作者：

Roederer, Mario ^{[1
]}

Keele, Brandon F. ^{[2
]}

Schmidt, Stephen D. ^{[1
]}

Mason, Rosemarie D. ^{[1
]}

Welles, Hugh C. ^{[1
,3
]}

Fischer, Will ^{[4
]}

Labranche, Celia ^{[5
]}

Foulds, Kathryn E. ^{[1
]}

Louder, Mark K. ^{[1
]}

Yang, Zhi-Yong ^{[1
]}

Todd, John-Paul M. ^{[1
]}

Buzby, Adam P. ^{[6
]}

Mach, Linh V. ^{[6
]}

Shen, Ling ^{[6
]}

Seaton, Kelly E. ^{[7
]}

Ward, Brandy M. ^{[5
]}

Bailer, Robert T. ^{[1
]}

Gottardo, Raphael ^{[8
]}

Gu, Wenjuan ^{[9
]}

Ferrari, Guido ^{[5
]}

Alam, S. Munir ^{[7
]}

Denny, Thomas N. ^{[7
]}

Montefiori, David C. ^{[5
]}

Tomaras, Georgia D. ^{[7
]}

Korber, Bette T. ^{[4
]}

Nason, Martha C. ^{[9
]}

Seder, Robert A. ^{[1
]}

Koup, Richard A. ^{[1
]}

Letvin, Norman L. ^{[6
]}

Rao, Srinivas S. ^{[1
]}

Nabel, Gary J. ^{[1
]}

Mascola, John R. ^{[1
]}

机构：

[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA

[2] NIH, SAIC Frederick, Frederick Natl Lab, Frederick, MD 21702 USA

[3] George Washington Univ, Washington, DC 20052 USA

[4] Los Alamos Natl Labs, Los Alamos, NM 87545 USA

[5] Duke Univ, Dept Surg, Durham, NC 27710 USA

[6] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA

[7] Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA

[8] Fred Hutchison Canc Res Ctr, Seattle, WA 98109 USA

[9] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA

来源：

NATURE | 2014年 / 505卷 / 7484期

关键词：

SIMIAN IMMUNODEFICIENCY VIRUS; DOSE CHALLENGE EXPERIMENTS; NEUTRALIZING ANTIBODIES; RHESUS MACAQUES; CELL RESPONSES; EFFICACY TRIAL; INFECTION; BINDING; SIVSME660; PREVENTION;

D O I：

10.1038/nature12893

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A major challenge for the development of a highly effective AIDS vaccine is the identification of mechanisms of protective immunity. To address this question, we used a nonhuman primate challenge model with simian immunodeficiency virus (SIV). We show that antibodies to the SIV envelope are necessary and sufficient to prevent infection. Moreover, sequencing of viruses from breakthrough infections revealed selective pressure against neutralization-sensitive viruses; we identified a two-amino-acid signature that alters antigenicity and confers neutralization resistance. A similar signature confers resistance of human immunodeficiency virus (HIV)-1 to neutralization by monoclonal antibodies against variable regions 1 and 2 (V1V2), suggesting that SIV and HIV share a fundamental mechanism of immune escape from vaccine-elicited or naturally elicited antibodies. These analyses provide insight into the limited efficacy seen in HIV vaccine trials.

引用

页码：502 / +

页数：17

共 50 条

[21] Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
Macagno, Marco
Bandini, Silvio
Bolli, Elisabetta
Bello, Amanda
Riccardo, Federica
Barutello, Giuseppina
Merighi, Irene Fiore
Forni, Guido
Lamolinara, Alessia
Del Pizzo, Francesco
Iezzi, Manuela
Cavallo, Federica
Conti, Laura
Quaglino, Elena
BIOMEDICINES, 2022, 10 (02)
[22] VACCINE PROTECTION OF RHESUS MACAQUES AGAINST SIV INFECTION
CARLSON, JR
MCGRAW, TP
KEDDIE, E
JENNINGS, MB
LANGLOIS, AJ
DICKOVER, R
DONOVAN, R
LUCIW, P
GARDNER, MB
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 158 - 159
[23] PROTECTION AGAINST VAGINAL SIV TRANSMISSION WITH MICROENCAPSULATED VACCINE
MARX, PA
COMPANS, RW
GETTIE, A
STAAS, JK
GILLEY, RM
MULLIGAN, MJ
YAMSHCHIKOV, GV
CHEN, DX
ELDRIDGE, JH
SCIENCE, 1993, 260 (5112) : 1323 - 1327
[24] Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, Patricia A.
Patel, Dipti T.
De Luca, Paula M.
Lindsay, Ross W. B.
Davey, Dylan F.
Flynn, Barbara J.
Hoff, Soren T.
Andersen, Peter
Reed, Steven G.
Morris, Sheldon L.
Roederer, Mario
Seder, Robert A.
NATURE MEDICINE, 2007, 13 (07) : 843 - 850
[25] Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxin
Van Slyke, Greta
Ehrbar, Dylan J.
Doering, Jennifer
Yates, Jennifer L.
Vitetta, Ellen S.
Donini, Oreola
Mantis, Nicholas J.
VACCINE, 2020, 38 (43) : 6721 - 6729
[26] Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani
Arnaud Marchant
Tobias R. Kollmann
Nature Reviews Immunology, 2021, 21 : 475 - 484
[27] Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Sadarangani, Manish
Marchant, Arnaud
Kollmann, Tobias R.
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (08) : 475 - 484
[28] A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials
Ehrenberg, Philip K.
Shangguan, Shida
Issac, Biju
Alter, Galit
Geretz, Aviva
Izumi, Taisuke
Bryant, Christopher
Eller, Michael A.
Wegmann, Frank
Apps, Richard
Creegan, Matthew
Bolton, Diane L.
Sekaly, Rafick P.
Robb, Merlin L.
Gramzinski, Robert A.
Pau, Maria G.
Schuitemaker, Hanneke
Barouch, Dan H.
Michael, Nelson L.
Thomas, Rasmi
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (507)
[29] Emerging role of γδ T cells in vaccine-mediated protection from infectious diseases
Dantzler, Kathleen W.
de la Parte, Lauren
Jagannathan, Prasanna
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (08)
[30] Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage
Merani, Shahzma
Kuchel, George A.
Kleppinger, Alison
McElhaney, Janet E.
EXPERIMENTAL GERONTOLOGY, 2018, 107 : 116 - 125

← 1 2 3 4 5 →